Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCYBA.L Regulatory News (CYBA)

  • There is currently no data for CYBA

Regulatory Approval

20 Oct 2021 07:00

RNS Number : 5908P
CYBA PLC
20 October 2021
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

20 October 2021

 

CYBA plc

 

CFIUS approval received

 

CYBA plc ("CYBA" or the "Company") is pleased to announce that the Company has now been provided with clearance from the Committee on Foreign Investment in the United States ("CFIUS") on the acquisition of Narf Industries LLC and Narf Industries PR LLC (the "Transaction"). Accordingly, all required US regulatory approvals in relation to the Transaction have now been obtained.

 

 

 

ENDS

 

 

 

About CYBA plc

CYBA plc ("CYBA") is a special purpose acquisition company ("SPAC") seeking suitable acquisition targets in the Cyber Security sector. CYBA intends to implement its strategy focussed on building a group capable of offering Cyber and Cybersecurity solutions in the US and beyond.

 

The Company intends to leverage the deep industry knowledge of its board and associates to undertake due diligence on the commercial attributes of a target entity's business.

 

For further information on the Company please visit www.cybaplc.com, with the Company's Prospectus to be found at www.cybaplc.com/investor-relations/corporate-documents or contact:

 

Robert Mitchell

 

CYBA

Tel: +44 (0) 20 3468 2212

Peter Krens

Tennyson Securities

Tel: +44 (0)207 186 9030

 

 

Forward-looking statements

Certain statements in announcements constitute ''forward-looking statements''. Forward-looking statements include statements concerning the plans, objectives, goals, strategies and future operations and performance of the Company and the assumptions underlying these forward-looking statements. The Company uses the words ''anticipates'', ''estimates'', ''expects'', ''believes'', ''intends'', ''plans'', ''may'', ''will'', ''should'', and any similar expressions to identify forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause the Company's actual results, performances or achievements to be materially different from any future results, performances or achievements expressed or implied by such forward-looking statements. Such forward-looking statements are based on numerous assumptions regarding present and future business strategies and the environment in which the Company will operate in the future. These forward-looking statements speak only as at the date of this announcement. The Company is not obliged, and does not intend, to update or to revise any forward-looking statements, whether as a result of new information, future events or otherwise except to the extent required by any applicable law or regulation. All subsequent written or oral forward-looking statements attributable to the Company, or persons acting on behalf of the Company, are expressly qualified in their entirety by the cautionary statements contained throughout this announcement. As a result of these risks, uncertainties and assumptions, a prospective investor should not place undue reliance on these forward-looking statements.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
REAKZMMGRLMGMZM
Date   Source Headline
4th Aug 202212:00 pmRNSChange of Name
28th Jul 20225:00 pmRNSResult of AGM & Change of Name
25th Jul 20227:00 amRNSTIGR Contract
6th Jul 20227:00 amRNSNotice of AGM
30th Jun 20227:00 amRNSFinal Results
20th Jun 20227:00 amRNSCorporate Update
27th May 202212:00 pmRNSIssue of Equity
16th May 20227:00 amRNSIssue of Equity
4th Apr 20223:45 pmRNSHolding(s) in Company
4th Apr 20223:45 pmRNSHolding(s) in Company
4th Apr 20223:45 pmRNSHolding(s) in Company
4th Apr 20222:18 pmRNSDirector/PDMR Shareholding
1st Apr 20223:42 pmRNSHolding(s) in Company
1st Apr 20223:30 pmRNSDirector/PDMR Shareholding
1st Apr 20223:27 pmRNSDirector/PDMR Shareholding
1st Apr 20221:43 pmRNSDirector/PDMR Shareholding
16th Mar 20227:02 amRNSAgreement
15th Mar 202210:19 amRNSReadmission of Enlarged Group
14th Mar 202211:47 amRNSGM Statement
17th Feb 20228:30 amRNSNarf Acquisition and Approved Prospectus
2nd Feb 20227:00 amRNSStatement re completion of fundraise
19th Jan 202211:05 amRNSSecond Price Monitoring Extn
19th Jan 202211:00 amRNSPrice Monitoring Extension
18th Jan 20227:00 amRNSTarget company - Polyswarm NCT Price Movement
10th Dec 202111:00 amRNSPrice Monitoring Extension
29th Oct 20218:00 amRNSContract
29th Oct 20217:00 amRNSHalf-year Report
20th Oct 20217:00 amRNSRegulatory Approval
29th Jul 20217:00 amRNSAcquisition Update
22nd Jul 202112:26 pmRNSHolding(s) in Company
6th Jul 20212:37 pmRNSHolding(s) in Company
30th Jun 202110:30 amRNSAudited results - nine months to 31 December 2020
25th Jun 20219:16 amRNSHolding(s) in Company
23rd Jun 20216:04 pmRNSHolding(s) in Company
21st Jun 20214:41 pmRNSSecond Price Monitoring Extn
21st Jun 20214:36 pmRNSPrice Monitoring Extension
21st Jun 202112:43 pmRNSAcquisition
13th May 20217:17 amRNSIssue of Equity
28th Apr 20217:00 amRNSInitial Application for trading on US OTCQB
8th Mar 20217:00 amRNSAdmission to Trading & First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.